About the journal
RSC Medicinal Chemistry is a journal published by Royal Society of Chemistry in United Kingdom. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Royal Society of Chemistry
- ISSN
- 2632-8682
- Country
- United Kingdom
- Access
- Not open access / not declared
Index listings
- PUBMED · 2020-01-01
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1790
Last recorded publication year
2026
h-index
50
i10-index
453
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 86%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Royal Society of Chemistry medicinal chemistry
- Source type
- journal
- NLM unique ID (PubMed)
- 101759460
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Synthesis and biological activity
- Synthesis and biological activity
- Click Chemistry and Applications
- Click Chemistry and Applications
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Cancer therapeutics and mechanisms
- Protein Degradation and Inhibitors
Show all subjects (50)
- Cancer therapeutics and mechanisms
- Protein Degradation and Inhibitors
- Synthesis and Biological Evaluation
- Synthesis and Biological Evaluation
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Chemical Synthesis and Analysis
- Chemical Synthesis and Analysis
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Cholinesterase and Neurodegenerative Diseases
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Bioactive Compounds and Antitumor Agents
- Cholinesterase and Neurodegenerative Diseases
- Bioactive Compounds and Antitumor Agents
- Quinazolinone synthesis and applications
- Quinazolinone synthesis and applications
- Mathematics, Computing, and Information Processing
- Mathematics, Computing, and Information Processing
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Antimicrobial Peptides and Activities
- Antimicrobial Peptides and Activities
- Biochemical and Molecular Research
- Phenothiazines and Benzothiazines Synthesis and Activities
- Biochemical and Molecular Research
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Characterization of Heterocyclic Compounds
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Research on Leishmaniasis Studies
- Research on Leishmaniasis Studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ